Drug Shortage Report for DEPO-PROVERA
Report ID | 131489 |
Drug Identification Number | 00585092 |
Brand name | DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML |
Common or Proper name | DEPO-PROVERA |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MEDROXYPROGESTERONE ACETATE |
Strength(s) | 150MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 5 x 1ML |
ATC code | G03AC |
ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-07-01 |
Actual start date | 2021-07-06 |
Estimated end date | 2023-06-01 |
Actual end date | 2022-08-05 |
Shortage status | Resolved |
Updated date | 2022-12-20 |
Company comments | Product discontinued, see posting 178960. Other presentation available, pre-filled syringes (DIN 02523493) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2021-01-12 | French | Compare |
v1 | 2021-01-12 | English | Compare |